Six-week group pain-education program for people with chronic pain
Official title: Physical Activity in Patients With Chronic Pain, Its Adherence to WHO Physical Activity Recommendations, and Its Associations With Kinesiophobia, Central Sensitization, Depression, and Pain Intensity
Run by University of Tartu · NCT07491549 · Data updated 2026-11-12
This six-week group program will try to help adults with chronic pain reduce pain and depression, lower fear of movement, and increase physical activity.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 16 Years to 65 Years |
| Sex | All |
| Enrollment | 50 (estimated) |
| Sponsor | University of Tartu Academic / other |
| Locations | 1 site (Tartu, Tartu) |
| Status | Recruiting |
| Started | April 1, 2026 |
| Main results expected | May 31, 2030 |
| Study ends | December 30, 2030 |
| Registry record updated | March 30, 2026 |
| Trial ID | NCT07491549 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults with persistent pain for more than three months who report reduced activity, sleep disturbances, fatigue, or low mood are ideal candidates.
✕Probably not a fit
People with recent surgery or a fracture/limb trauma within the past three months, or those requiring urgent medical or surgical care, may not benefit from this program.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
Participants join a single-arm, six-week pain education group at Tartu University Hospital where weekly sessions cover sleep, stress models, benefits of physical activity, pain neurobiology, mindfulness, and pain medication. The intervention is educational and delivered in group format without a comparison arm. Outcomes measured before and after the program include physical activity, pain intensity, depression, kinesiophobia (fear of movement), and signs of central sensitization. Eligible participants are adults with pain lasting more than three months and related consequences like reduced activity, poor sleep, fatigue, or low mood.
Why it matters
Potential benefit: If successful, the program could help participants experience less pain and depression, reduce fear of movement, and increase daily physical activity.
How similar studies have gone: Similar pain-education and pain neuroscience education programs have shown mixed but generally encouraging results for reducing pain, kinesiophobia, and boosting activity when used alone or alongside other therapies.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Pain lasting longer than 3 months, * Consequences resulting from long-term pain (such as decreased physical activity, sleep disturbances, fatigue, low mood, etc.) Exclusion Criteria: * Surgery that occurred less than 3 months prior * Fracture or limb trauma that occurred less than 3 months prior
Where it's running
-
Tartu University Hospital
Tartu, Tartu, Estonia Recruiting
Study contacts
- Study coordinator: Hanna Kalajas-Tilga, PhD
- Email: hanna.kalajas-tilga@ut.ee
- Phone: +372 5816 1041
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Cognitive Rehabilitation of Everyday Goals With GMT: How Different Ways of Delivery Work
This study tests Goal Management Training to see if a Swedish version helps adults with acquired brain injury or chronic pain improve practical goal-directed thinking and daily functioning.
-
One-time Pain Reprocessing Therapy session for chronic pain at The Ottawa Hospital
A single four-hour session of Pain Reprocessing Therapy is being tested to see if it can help adults with chronic pain feel better and have less pain.
-
Meaning-Based Psychotherapy for Adults with Chronic Pain
This trial tests whether Meaning-Based Psychotherapy helps adults with chronic pain feel more purposeful, feel less depressed, and have a better quality of life compared with optimized usual care therapy.
-
How chronic pain changes over time in kids with Duchenne Muscular Dystrophy
This study is following children and teens with Duchenne Muscular Dystrophy for 6 months to see how their chronic pain changes and how it affects daily life.
-
CBD for Opioid Dependence and Pain on Buprenorphine
This study tests whether different doses of cannabidiol (CBD) can affect pain and opioid cravings in adults with opioid use disorder who are on buprenorphine, using a short, randomized, placebo-controlled setup.
-
Cebranopadol for opioid withdrawal in adults with chronic pain
This study tests whether cebranopadol can reduce withdrawal symptoms in adults with chronic pain who are physically dependent on prescribed opioids, compared with placebo.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.